(FY)Oct 31, 2021 | (Q4)Oct 31, 2021 | (Q3)Jul 31, 2021 | (Q2)Apr 30, 2021 | (Q1)Jan 31, 2021 | (FY)Oct 31, 2020 | (Q4)Oct 31, 2020 | (Q3)Jul 31, 2020 | (Q2)Apr 30, 2020 | (Q1)Jan 31, 2020 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -177.59%-108.31M | -3.65%-98.08M | 78.66%26.7M | -104.50%-10.45M | -101.59%-26.48M | 605.74%139.6M | -393.70%-94.62M | 220.54%14.95M | 599.74%232.4M | 60.50%-13.14M |
Net income from continuing operations | 15.33%22.38M | 24.53%5.91M | 24.42%5.44M | 11.56%5.74M | 2.90%5.29M | -3.92%19.41M | -12.19%4.75M | -11.97%4.37M | 5.17%5.15M | 4.24%5.14M |
Operating gains losses | --743K | ---495K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Depreciation and amortization | 50.48%1.73M | 56.70%456K | 24.86%452K | 77.14%372K | 56.99%449K | 59.36%1.15M | 68.21%291K | 43.08%362K | 82.61%210K | 58.89%286K |
Provision for loans, leases and other losses | 6.40%-322K | 52.06%-279K | 318.18%96K | -140.00%-196K | 127.40%57K | -15.44%-344K | -2,871.43%-582K | -111.55%-44K | 219.22%490K | 28.03%-208K |
Deferred tax | 14.45%8.41M | 23.85%2.23M | 20.52%2M | 12.79%2.2M | 2.26%1.99M | -3.65%7.35M | -11.73%1.8M | -11.58%1.66M | 5.19%1.95M | 4.40%1.94M |
Other non cashItems | -11.14%-60.16M | -17.79%-16.15M | -17.43%-14.54M | -4.28%-15.1M | -6.03%-14.37M | -0.42%-54.13M | -0.39%-13.71M | 11.91%-12.38M | -13.60%-14.48M | -0.87%-13.56M |
Change in working capital | -218.09%-134.29M | -4.43%-104.48M | 130.74%14.98M | -106.60%-14.82M | -72.30%-29.97M | 1,984.23%113.71M | -517.89%-100.05M | 133.46%6.49M | 613.64%224.66M | 58.63%-17.4M |
-Change in loans | -673.00%-443.68M | -42.00%-149.43M | -355.11%-121.36M | -147.54%-34.99M | -88.05%-137.91M | -242.33%-57.4M | -639.71%-105.23M | 201.37%47.57M | 495.41%73.6M | -409.98%-73.34M |
-Change in other working capital | 80.82%309.4M | 766.83%44.95M | 431.90%136.34M | -86.65%20.17M | 92.95%107.93M | 469.07%171.11M | 16.72%5.19M | -16.74%-41.08M | 201.56%151.06M | 185.13%55.94M |
Interest paid (cash flow from operating activities) | 0.36%-30.8M | -16.30%-7.58M | 33.03%-3.82M | -11.47%-8.92M | 1.91%-10.49M | 8.20%-30.91M | 18.19%-6.52M | 24.10%-5.71M | -10.96%-8M | 2.65%-10.69M |
Interest received (cash flow from operating activities) | 2.43%85.39M | 17.13%22.72M | 5.43%21.3M | -7.22%20.8M | -3.63%20.57M | -2.09%83.36M | -12.85%19.4M | -4.33%20.2M | 47.18%22.42M | -19.57%21.35M |
Tax refund paid | ---1.39M | ---418K | ---431K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
Cash from discontinued operating activities | ||||||||||
Operating cash flow | -177.59%-108.31M | -3.65%-98.08M | 78.66%26.7M | -104.50%-10.45M | -101.59%-26.48M | 605.74%139.6M | -393.70%-94.62M | 220.54%14.95M | 599.74%232.4M | 60.50%-13.14M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -186.52%-8.44M | 1,866.67%53K | 0 | -258.27%-953K | -175.67%-7.54M | 4,130.99%9.76M | 94.55%-3K | 175.95%60K | -632.00%-266K | 6,406.33%9.96M |
Net PPE purchase and sale | 94.29%-14K | 1,866.67%53K | --0 | --0 | -86.11%-67K | -1.24%-245K | 94.55%-3K | 175.95%60K | -632.00%-266K | 77.22%-36K |
Net business purchase and sale | ---7.47M | --0 | --0 | --0 | ---7.47M | --0 | --0 | --0 | --0 | --0 |
Net investment purchase and sale | -109.53%-953K | --0 | --0 | ---953K | --0 | --10M | --0 | --0 | --0 | --10M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -186.52%-8.44M | 1,866.67%53K | --0 | -258.27%-953K | -175.67%-7.54M | 4,130.99%9.76M | 94.55%-3K | 175.95%60K | -632.00%-266K | 6,406.33%9.96M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 525.93%131.4M | 4,817.59%72.13M | 39.04%-937K | 375.54%71.82M | -574.55%-11.61M | -203.23%-30.85M | -16.27%-1.53M | -16.97%-1.54M | -308.78%-26.06M | -47.22%-1.72M |
Net issuance payments of debt | 416.80%78.84M | -94.05%-163K | -78.02%-162K | 462.87%89.34M | -11,207.78%-10.18M | -385.56%-24.89M | ---84K | ---91K | -380.39%-24.62M | ---90K |
Net commonstock issuance | --73.23M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Net preferred stock issuance | ---16.81M | --0 | --0 | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
Cash dividends paid | 10.14%-3.85M | 12.99%-931K | 27.57%-775K | 0.00%-1.07M | 0.00%-1.07M | -16.37%-4.28M | -10.08%-1.07M | -10.08%-1.07M | -23.41%-1.07M | -23.41%-1.07M |
Net other financing activities | ---- | ---- | ---- | ---- | 35.47%-362K | -22.98%-1.69M | -9.33%-375K | -9.94%-376K | 2.60%-374K | -85.76%-561K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 525.93%131.4M | 4,817.59%72.13M | 39.04%-937K | 375.54%71.82M | -574.55%-11.61M | -203.23%-30.85M | -16.27%-1.53M | -16.97%-1.54M | -308.78%-26.06M | -47.22%-1.72M |
Net cash flow | ||||||||||
Beginning cash position | 85.16%257.64M | -16.05%297.01M | -19.95%272.43M | 57.92%212.02M | 85.16%257.64M | 7.22%139.15M | 226.68%353.79M | 178.75%340.33M | 41.02%134.25M | 7.22%139.15M |
Current changes in cash | -87.63%14.66M | 73.07%-25.89M | 91.30%25.76M | -70.68%60.41M | -832.71%-45.63M | 1,165.47%118.5M | -411.71%-96.15M | 197.66%13.47M | 666.44%206.07M | 85.85%-4.89M |
Effect of exchange rate changes | ---779K | --408K | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
End cash position | 5.39%271.52M | 5.39%271.52M | -16.05%297.01M | -19.95%272.43M | 57.92%212.02M | 85.16%257.64M | 85.16%257.64M | 226.68%353.79M | 178.75%340.33M | 41.02%134.25M |
Free cash from | -177.73%-108.32M | -3.59%-98.02M | 77.95%26.7M | -104.50%-10.45M | -101.55%-26.55M | 613.23%139.35M | -394.21%-94.62M | 220.26%15.01M | 597.88%232.14M | 60.58%-13.17M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.